455 related articles for article (PubMed ID: 18587715)
1. Supportive Versus Immunosuppressive Therapy of Progressive IgA nephropathy (STOP) IgAN trial: rationale and study protocol.
Eitner F; Ackermann D; Hilgers RD; Floege J
J Nephrol; 2008; 21(3):284-9. PubMed ID: 18587715
[TBL] [Abstract][Full Text] [Related]
2. Effects of Two Immunosuppressive Treatment Protocols for IgA Nephropathy.
Rauen T; Fitzner C; Eitner F; Sommerer C; Zeier M; Otte B; Panzer U; Peters H; Benck U; Mertens PR; Kuhlmann U; Witzke O; Gross O; Vielhauer V; Mann JFE; Hilgers RD; Floege J
J Am Soc Nephrol; 2018 Jan; 29(1):317-325. PubMed ID: 29042456
[TBL] [Abstract][Full Text] [Related]
3. IgA nephropathy with severe chronic renal failure: a randomized controlled trial of corticosteroids and azathioprine.
Pozzi C; Andrulli S; Pani A; Scaini P; Roccatello D; Fogazzi G; Pecchini P; Rustichelli R; Finocchiaro P; Del Vecchio L; Locatelli F
J Nephrol; 2013; 26(1):86-93. PubMed ID: 22460183
[TBL] [Abstract][Full Text] [Related]
4. Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial.
Li S; Li JP
Trials; 2020 Jan; 21(1):31. PubMed ID: 31907076
[TBL] [Abstract][Full Text] [Related]
5. Low-dose sirolimus combined with angiotensin-converting enzyme inhibitor and statin stabilizes renal function and reduces glomerular proliferation in poor prognosis IgA nephropathy.
Cruzado JM; Poveda R; Ibernón M; Díaz M; Fulladosa X; Carrera M; Torras J; Bestard O; Navarro I; Ballarín J; Romero R; Grinyó JM
Nephrol Dial Transplant; 2011 Nov; 26(11):3596-602. PubMed ID: 21393611
[TBL] [Abstract][Full Text] [Related]
6. Pro: STOP immunosuppression in IgA nephropathy?
Pozzi C
Nephrol Dial Transplant; 2016 Nov; 31(11):1766-1770. PubMed ID: 27515694
[TBL] [Abstract][Full Text] [Related]
7. Intensive Supportive Care plus Immunosuppression in IgA Nephropathy.
Rauen T; Eitner F; Fitzner C; Sommerer C; Zeier M; Otte B; Panzer U; Peters H; Benck U; Mertens PR; Kuhlmann U; Witzke O; Gross O; Vielhauer V; Mann JF; Hilgers RD; Floege J;
N Engl J Med; 2015 Dec; 373(23):2225-36. PubMed ID: 26630142
[TBL] [Abstract][Full Text] [Related]
8. Treatment of progressive IgA nephropathy: an update.
Wang W; Chen N
Contrib Nephrol; 2013; 181():75-83. PubMed ID: 23689569
[TBL] [Abstract][Full Text] [Related]
9. Randomized controlled trial of mycophenolate mofetil in children, adolescents, and adults with IgA nephropathy.
Hogg RJ; Bay RC; Jennette JC; Sibley R; Kumar S; Fervenza FC; Appel G; Cattran D; Fischer D; Hurley RM; Cerda J; Carter B; Jung B; Hernandez G; Gipson D; Wyatt RJ
Am J Kidney Dis; 2015 Nov; 66(5):783-91. PubMed ID: 26209543
[TBL] [Abstract][Full Text] [Related]
10. [Immunosuppressive therapy in IgA glomerulonephritis with chronic renal failure: case study presentation and literature review].
Pozzi C; Del Vecchio L; Locatelli F
G Ital Nefrol; 2002; 19(5):523-8. PubMed ID: 12439840
[TBL] [Abstract][Full Text] [Related]
11. Mycophenolic acid therapy after cyclophosphamide pulses in progressive IgA nephropathy.
Rasche FM; Keller F; von Müller L; Sailer LK; Karges W; Czock D
J Nephrol; 2006; 19(4):465-72. PubMed ID: 17048204
[TBL] [Abstract][Full Text] [Related]
12. The effects of cytotoxic therapy in progressive IgA nephropathy.
Shin JH; Lee JE; Park JH; Lim S; Jang HR; Kwon GY; Huh W; Jung SH; Kim YG; Oh HY; Kim DJ
Ann Med; 2016; 48(3):171-81. PubMed ID: 27031662
[TBL] [Abstract][Full Text] [Related]
13. Con: STOP immunosuppression in IgA nephropathy.
Rauen T; Eitner F; Fitzner C; Floege J
Nephrol Dial Transplant; 2016 Nov; 31(11):1771-1774. PubMed ID: 27515693
[TBL] [Abstract][Full Text] [Related]
14. Predictors of Progression in IgA Nephropathy in Childhood.
Mizerska-Wasiak M; Małdyk J; Turczyn A; Cichoń-Kawa K; Rybi-Szumińska A; Wasilewska A; Bieniaś B; Zajączkowska M; Miklaszewska M; Pietrzyk J; Demkow U; Roszkowska-Blaim M; Pańczyk-Tomaszewska M
Adv Exp Med Biol; 2017; 955():65-73. PubMed ID: 27718216
[TBL] [Abstract][Full Text] [Related]
15. Mycophenolate Mofetil Combined With Prednisone Versus Full-Dose Prednisone in IgA Nephropathy With Active Proliferative Lesions: A Randomized Controlled Trial.
Hou JH; Le WB; Chen N; Wang WM; Liu ZS; Liu D; Chen JH; Tian J; Fu P; Hu ZX; Zeng CH; Liang SS; Zhou ML; Zhang HT; Liu ZH
Am J Kidney Dis; 2017 Jun; 69(6):788-795. PubMed ID: 28215945
[TBL] [Abstract][Full Text] [Related]
16. Tacrolimus improves the proteinuria remission in patients with refractory IgA nephropathy.
Zhang Q; Shi SF; Zhu L; Lv JC; Liu LJ; Chen YQ; Zhang H; Wang HY
Am J Nephrol; 2012; 35(4):312-20. PubMed ID: 22456060
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppression in IgA nephropathy: how certain are we?
Floege J; Rauen T
Kidney Int; 2016 Jan; 89(1):9-11. PubMed ID: 26759037
[TBL] [Abstract][Full Text] [Related]
18. Combined treatment with steroids and azathioprine in IgA nephropathy: design of a prospective randomised multicentre trial.
Locatelli F; Pozzi C; Del Vecchio L; Andrulli S; Pani A; Fogazzi G; Altieri P; Ponticelli C
J Nephrol; 1999; 12(5):308-11. PubMed ID: 10630693
[TBL] [Abstract][Full Text] [Related]
19. Non-immunosuppressive treatment for IgA nephropathy.
Reid S; Cawthon PM; Craig JC; Samuels JA; Molony DA; Strippoli GF
Cochrane Database Syst Rev; 2011 Mar; (3):CD003962. PubMed ID: 21412884
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the effectiveness of cyclophosphamide, leflunomide, corticosteroids, or conservative management alone in patients with IgA nephropathy: a retrospective observational study.
Chen S; Yin Q; Ren S; Zhong X; Wang W; Li G; Wang L
Sci Rep; 2018 Sep; 8(1):13662. PubMed ID: 30209279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]